Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin prophylaxis for post-ERCP acute pancreatitis
2008-003338-41Phase 3Active
- Sponsor
- Cristina Gómez Oliva
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of somatostatin in acute pancreatitis (AP) (2 arms), sponsored by Cristina Gómez Oliva. Primary endpoints: Pre-procedure baseline parameters and risk factors, Incidence of post-ERCP pancreatitis and 2 more. Started Feb 2010; status: active.
02
Drugs
somatostatin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on 2008-003338-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003338-41.